News & Views

 

featured

Can Your Seed Stage Investors Go the Distance?

- Matt McIlwain

More views  
January 6, 2020

Today, we’re excited to announce that Madrona has led the $16M Series A investment in TwinStrand Biosciences, a Seattle genomics company with the potential to profoundly impact all of us. TwinStrand’s technology will help detect cancer earlier when it can be most… READ MORE